1)Fishman JA:Infection in solid-organ transplant recipients. N Engl J Med 357:2601-2614,2007
2)Bennett JE, Dolin R, Blaser MJ (eds):Mandell, Douglas, and Bennett's Principles & Practice of Infectious Diseases, 9th ed, Elsevier, Philadelphia, PA, 2019
3)Carugati M, Arif S, Sudan DL, et al:Epidemiology of surgical site infections after solid organ transplants in the period 2015-2019: A single-center retrospective cohort study. Am J Transplant 22:3021-3030,2022
4)Wright AJ, Fishman JA:Central nervous system syndromes in solid organ transplant recipients. Clin Infect Dis 59:1001-1011,2014
5)Avila JD, Živković S:The neurology of solid organ transplantation. Curr Neurol Neurosci Rep 15:38,2015
6)van den Bogaart L, Lang BM, Rossi S, et al:Central nervous system infections in solid organ transplant recipients: Results from the Swiss Transplant Cohort Study. J Infect 85:1-7,2022
7)van Veen KE, Brouwer MC, van der Ende A, et al:Bacterial meningitis in solid organ transplant recipients: a population-based prospective study. Transpl Infect Dis 18:674-680,2016
8)Tamzali Y, Scemla A, Bonduelle T, et al:Specificities of Meningitis and Meningo-Encephalitis After Kidney Transplantation: A French Retrospective Cohort Study. Transpl Int 36:10765,2023
9)Wolfe CR, Ison MG, AST Infectious Diseases Community of Practice:Donor-derived infections: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 33:e13547,2019
10)Vora NM, Basavaraju SV, Feldman KA, et al:Raccoon rabies virus variant transmission through solid organ transplantation. JAMA 310:398-407,2013
11)Lee DH, Zuckerman RA, AST Infectious Diseases Community of Practice:Herpes simplex virus infections in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 33:e13526,2019
12)Pergam SA, Limaye AP, AST Infectious Diseases Community of Practice:Varicella zoster virus in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 33:e13622,2019
13)Lenfant T, L'Honneur AS, Ranque B, et al:Neurological complications of varicella zoster virus reactivation: Prognosis, diagnosis, and treatment of 72 patients with positive PCR in the cerebrospinal fluid. Brain Behav 12:e2455,2022
14)グラクソ・スミスクライン株式会社:GSK,帯状疱疹予防ワクチン「シングリックス筋注用」の接種対象者拡大〜帯状疱疹の発症リスクが高いと考えられる18歳以上を対象として,用法及び用量追加に係る製造販売承認事項一部変更承認を取得〜,2023(https://jp.gsk.com/ja-jp/news/press-releases/20230626-shingrix/)(最終アクセス:2023年7月10日)
15)Ljungman P, Boeckh M, Hirsch HH, et al:Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials. Clin Infect Dis 64:87-91,2017
16)Maschke M, Kastrup O, Diener HC:CNS manifestations of cytomegalovirus infections: diagnosis and treatment. CNS Drugs 16:303-315,2002
17)Razonable RR, Humar A:Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 33:e13512,2019
18)Allen UD, Preiksaitis JK, AST Infectious Diseases Community of Practice:Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 33:e13652,2019
19)Kempf C, Tinguely M, Rushing EJ:Posttransplant lymphoproliferative disorder of the central nervous system. Pathobiology 80:310-318,2013
20)日本移植学会臓器移植関連EBV感染症診療ガイドライン策定委員会(編):臓器移植関連EBV感染症診療ガイドライン2021年版,メディカルレビュー社,2021
21)Restrepo A, Clark NM, Infectious Diseases Community of Practice of the American Society of Transplantation:Nocardia infections in solid organ transplantation: Guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation. Clin Transplant 33:e13509,2019
22)Takamatsu A, Yaguchi T, Tagashira Y, et al:Nocardiosis in Japan: a Multicentric Retrospective Cohort Study. Antimicrob Agents Chemother 66:e0189021,2022
23)Meena DS, Kumar D, Bohra GK, et al:Clinical manifestations, diagnosis, and treatment outcome of CNS aspergillosis: A systematic review of 235 cases. Infect Dis Now 51:654-660,2021
24)Husain S, Camargo JF:Invasive Aspergillosis in solid-organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 33:e13544,2019
25)Donnelly JP, Chen SC, Kauffman CA, et al:Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis 71:1367-1376,2020
26)Forster J, Hoenigl M, Suerbaum S, et al:Serologic biomarkers in Candida and Aspergillus infections of the central nervous system: A comparison of galactomannan, mannan and β-1,3-D-gucan testing from serum and cerebrospinal fluid. Mycoses 65:709-714,2022
27)Baddley JW, Forrest GN, AST Infectious Diseases Community of Practice:Cryptococcosis in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 33:e13543,2019
28)La Hoz RM, Morris MI, Infectious Diseases Community of Practice of the American Society of Transplantation:Tissue and blood protozoa including toxoplasmosis, Chagas disease, leishmaniasis, Babesia, Acanthamoeba, Balamuthia, and Naegleria in solid organ transplant recipients- Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 33:e13546,2019